Vol. 279, Issue 6, H2939-H2946, December 2000
Diastolic wall stress and ANG II in cardiac hypertrophy and
gene expression induced by volume overload
Hiroshi
Yamakawa,
Takuroh
Imamura,
Takeshi
Matsuo,
Hisamitsu
Onitsuka,
Yoko
Tsumori,
Johji
Kato,
Kazuo
Kitamura,
Yasushi
Koiwaya, and
Tanenao
Eto
First Department of Internal Medicine, Miyazaki Medical College,
Miyazaki 889-1692, Japan
 |
ABSTRACT |
We investigated the
effects of diastolic wall stress (WS) and angiotensin II (ANG II) on
the left ventricular (LV) hypertrophy (LVH) induced by volume overload
and on the gene expression of LV adrenomedullin (AM) and atrial
natriuretic peptide (ANP) in volume overload. Diastolic WS was
pharmacologically manipulated with (candesartan) or without (calcium
channel blocker manidipine) inhibition of ANG II type 1 receptors in
aortocaval-shunted rats over 6 wk. Diastolic WS reached a plateau at 2 wk and subsequently declined regardless of further LVH. Although
diastolic WS was decreased to a similar extent by both compounds,
candesartan blunted LVH over 6 wk, whereas manidipine blunted LVH at 2 wk but not after 4 wk. Levels of AM and ANP gene expression increased
as LVH developed but were completely suppressed by candesartan over 6 wk. ANP expression level was also attenuated by manidipine over 6 wk,
whereas AM expression level was suppressed at 2 wk but not after 4 wk
by manidipine. We concluded that diastolic WS and ANG II might be
potent stimuli for the LVH and LV AM and ANP gene expression in volume
overload and that diastolic WS could be relatively involved in the
early LVH and in the gene expression of ANP rather than of AM.
aortocaval shunt; adrenomedullin; atrial natriuretic peptide; angiotensin II type 1 receptor antagonist; calcium channel blocker; left ventricular hypertropy
 |
INTRODUCTION |
INCREASED HEMODYNAMIC
LOAD produces different types of left ventricular (LV)
hypertrophy (LVH) through different processes of adaptation
(10). Pressure overload increases systolic tension, resulting in myocardial fiber thickening and concentric hypertrophy in
an effort to normalize systolic wall stress (WS) (10).
Similarly, diastolic WS is also believed to stimulate eccentric
hypertrophy in response to volume overload (6, 9).
However, diastolic WS is not normalized in volume overload-induced LVH
associated with aortic regurgitation (14) and aortocaval
(AC) shunt in the rat models (2, 5). In the AC shunt
model, LV end-diastolic pressure (LVEDP) rapidly increases after the
imposition of acute volume overload, peaks at an early phase, and
declines thereafter. Despite the decrease in LVEDP, LVH continues to
develop (2). These findings suggest that the contribution
of a load-dependent factor to the development of LVH decreases and that
of a load-independent factor alternatively increases during volume
overload imposed by AC shunt. However, the mechanisms of the further
progression of LVH in volume overload after the decrease in LVEDP and
the lowering effect of LVEDP on the suppression of LVH in volume
overload remain unclear.
The cardiac renin-angiotensin system (RAS) is activated in experimental
models with pressure and volume overload (16, 28). In
fact, load-independent factors, such as angiotensin II (ANG II) and
endothelin 1, also play important roles in LVH (15, 24),
as do load-dependent factors (18, 25) in vitro and in
vivo. However, whether or not the cardiac hypertrophy caused by
pressure overload is prevented by an ANG II type 1 (AT1)
receptor antagonist in vivo has remained controversial (3,
32). Harada et al. (11) reported that acute
pressure overload induces LVH in AT1a receptor knockout
mice as well as in wild-type mice. They suggested that the acute
hypertrophic response can be induced by pressure overload per se
without AT1 signaling (11). In contrast, they
also reported that LV remodeling after myocardial infarction was less
remarkable in AT1a receptor knockout mice than in wild-type mice (12). Taken together, these findings imply that the
magnitude of the role of mechanical stress and/or RAS differs between
pressure and volume overload-induced LVH. The influence of RAS on LVH
seems to be more critical in volume than in pressure overload.
LVH is characterized by an increase in cell size and is accompanied by
changes in the expression of several genes. Adrenomedullin (AM) and
atrial natriuretic peptide (ANP) are potent vasoactive peptides that
play roles in cardiovascular homeostasis and circulate in the blood,
and their genes are expressed in the heart (4, 27).
Cardiac AM and ANP gene expression levels increase in volume overload
produced by an AC shunt (13, 22) and in postmyocardial infarction (17), suggesting that AM and ANP also play
important roles in volume overload-induced LVH. We confirmed that the
plasma levels of AM and ANP are increased during the acute phase of the volume overload model and that the plasma concentrations of AM and ANP
increase according to different profiles (13). The former correlates with plasma renin activity and the latter correlates with
LVEDP (13).
Accordingly, we surmised that ANG II, in addition to LVEDP or diastolic
WS, might be a potent stimulus for AC shunt-induced LVH, that
pharmacological manipulation of LVEDP with or without inhibition of
AT1 receptor signaling might attenuate LVH by different means, and that LV AM and ANP gene expression might be differentially regulated as an autocrine or paracrine hormone in this model. To test
these hypotheses, we investigated whether LVH in the AC shunt rat model
is suppressed in a different manner by the AT1 receptor
antagonist candesartan and the calcium channel blocker manidipine over
6 wk, evaluated the ventricular expression level of AM and ANP mRNA
during volume overload, and examined whether or not the gene expression
is affected by candesartan or manidipine.
 |
METHODS |
Animals and experimental protocols.
Eight-week-old male Wistar rats (280-310 g), obtained from Charles
River (A-tsugi, Japan), were housed in a room at a controlled temperature under 12 h of light and 12 h of darkness. After
an acclimatization period of at least 3 days, we divided the animals into five groups as follows: sham operation (n = 21),
AC shunt with vehicle (AC + V; n = 20), AC shunt
with low-dose candesartan cilexetil (AC+L; 0.1 mg · kg
1 · day
1,
n = 20), AC shunt with high-dose candesartan cilexetil
(AC + H; 1 mg · kg
1 · day
1,
n = 20), and AC shunt with manidipine (AC + M; 10 mg · kg
1 · day
1,
n = 20). Drug administration commenced 3 days before
surgery and continued for 2, 4, and 6 wk thereafter. The AC shunt was constructed using 18-gauge disposable needles as described by Garcia
and Diebold (8). Sham-operated animals serving as controls underwent the same procedure but without the aorta and inferior vena
cava being punctured. To minimize operative stress, all procedures were
completed within 15 min. Drugs were suspended in 5% gum arabic and
were administered daily through the stomach by gastric gavage. Rats
were euthanized 2, 4, and 6 wk after the operation. All manipulations and care of the animals proceeded according to the guidelines for
Institutional Animal Care and Use of Laboratory Animals of Miyazaki
Medical College.
Hemodynamic measurements and echocardiographic evaluation.
Rats were anesthetized by an intraperitoneal administration of
pentobarbital sodium (50 mg/kg). Heart rate (HR), systolic aortic blood
pressure (SBP), LVEDP, and mean right atrial pressure (RAP) were
measured using a Statham pressure transducer (model P231D, Gould,
Saddle Brook, NJ) inserted into the ascending aorta and LV through the
right carotid artery and by another catheter placed in the right atrium
through the right jugular vein. An echocardiograph (model USI-738;
Aloka) equipped with a 7.5-MHz transducer obtained two-dimensional
short-axis views of the LV at the level of the papillary muscle. We
determined the LV end-diastolic dimension (LVEDD) and LV posterior wall
thickness by echocardiography. The LV diastolic WS was routinely
calculated according to the following formula: diastolic WS = LVEDP × r
2(LV wall thickness), where
r is radius of the LV.
Measurement of LV ANG II concentrations.
The LV ANG II concentrations in the sham and AC + V groups were
determined by extraction using florisil adsorption, elution with
acetone-hydrochloric acid, and radioimmunoassay.
RNA isolation and Northern blotting.
The total RNA isolated from rat LV tissues using TRIzol (Life
Technologies) according to the manufacturer's protocol was resolved by
electrophoresis on 1.0% agarose gels and transferred to nylon membranes (Immobilon probe, Millipore). The membranes were hybridized with 32P-labeled cDNA probes and then washed with 2× and
1× saline-sodium citrate. Radioactive signals on blots were
quantified using an image analyzer (BAS2000, Fuji Film). Results were
normalized to signals from GAPDH mRNA.
Statistical analysis.
All results are expressed as means ± SE. Differences among the
five groups were evaluated by the one-way analysis of variance followed
by Scheffé's test. An unpaired t-test was used to
compare LV ANG II concentrations between the AC + V and sham
groups in each time point. Differences were considered significant at
P < 0.05.
 |
RESULTS |
The changes in HR, mean RAP, and SBP are shown in Table
1. SBP did not differ between the AC + L and AC + V groups but was significantly decreased in the
AC + H and AC + M groups compared with the AC + V group
over 6 wk. SBP between the AC + H and AC + M groups did not
differ over 6 wk. Changes in LVEDP and diastolic WS over 6 wk
are shown in Figs. 1 and
2, respectively. Both LVEDP and diastolic
WS in all groups peaked at 2 wk and then gradually declined. However,
diastolic WS in the AC + V group remained high compared with that
in sham-operated rats at 6 wk (Fig. 2). Diastolic WS and LVEDP did not
significantly change among the AC + L, AC + H, and AC + M groups over 6 wk. Thus the changes in SBP and LVEDP were
hemodynamically very similar between the AC + H and AC + M
groups. These findings suggest that diastolic WS is directly related to
LVEDP independently of the inhibition of AT1
signaling. The values of LV weight-to-body weight ratio (LV/BW;
Fig. 3) and LVEDD (Fig.
4) in volume-overloaded rats were
significantly increased at all times between 2 and 6 wk compared with
those in the sham-operated rats (2.64 ± 0.09 mg/g and 8.80 ± 0.22 mm in volume-overloaded rats vs. 1.80 ± 0.02 mg/g and
6.71 ± 0.07 mm in sham-operated rats at 2 wk, respectively,
P < 0.01; 2.95 ± 0.09 mg/g and 9.40 ± 0.13 mm in volume-overloaded rats vs. 1.79 ± 0.03 mg/g and 7.00 ± 0.19 mm in sham-operated rats at 4 wk, respectively,
P < 0.01; and 3.00 ± 0.10 mg/g and 10.52 ± 0.33 mm in volume-overloaded rats vs. 1.83 ± 0.03 mg/g and
7.28 ± 0.07 mm in sham-operated rats at 6 wk, respectively,
P < 0.01). Candesartan (AC + L and AC + H
groups) significantly decreased LV/BW (P < 0.01) and
LVEDD (P < 0.01) over 6 wk compared with vehicle. In
contrast, LV/BW and LVEDD were significantly decreased by manidipine at
2 wk (P < 0.05 in LV/BW and P < 0.01 in LVEDD) compared with vehicle, but no significant decrease was
evident after 4 wk. Thus although similar hemodynamic effects on
hypertrophied myocardium were sustained over 6 wk in the AC + H
and AC + M groups, both compounds attenuated LVH at 2 wk, and only
candesartan blunted LVH after 4 wk. The LV/BW and diastolic WS values
significantly correlated (Fig. 5). The
LV/BW and LVEDP values also significantly correlated but those of SBP
and LV/BW did not. The LV ANG II concentrations in the AC + V
group were significantly higher (P < 0.05) than those
in the sham group at 2 and 6 wk, but the difference was not significant at 4 wk (Table 2).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Changes in left ventricular (LV) end-diastolic pressure
(LVEDP) 2, 4, and 6 wk after operation. LVEDP in all groups reached a
plateau at 2 wk and then gradually reduced. LVEDP in the aortocaval
shunt (AC) + vehicle (AC + V) group remained high at 6 wk
compared with sham. LVEDP in the AC + low-dose candesartan
(AC + L), AC + high-dose candesartan (AC + H), and
AC + manidipine (AC + M) groups were lower than that in the
AC + V group. The AC + L, AC + H, and AC+M groups did
not significantly differ (n = 6-7 rats/group).
Values are means ± SE. *P < 0.01 vs. sham;
**P < 0.05 vs. sham; #P < 0.01 vs.
AC + V group.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Changes in diastolic wall stress (WS) 2, 4, and 6 wk
after operation. Diastolic WS in all groups reached a plateau at 2 wk
and then gradually decreased. Diastolic WS in the AC + V group
remained high at 6 wk compared with sham; diastolic WS in the AC + L, AC + H, and AC + M groups were lower than that in the
AC + V group. The AC + L, AC + H, and AC + M groups
did not significantly differ (n = 6-7 rats/group).
Values are means ± SE. *P < 0.01 vs. sham;
**P < 0.05 vs. sham; #P < 0.01 vs.
the AC + V group.
|
|

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
LV
weight-to-body weight ratio (LV/BW) in sham, AC + V, AC + L,
AC + H, and AC + M groups 2, 4, and 6 wk after operation.
LV/BW significantly increased in rats in the AC + V group at 2 wk
with further increases over 6 wk. Increases in LV/BW in the AC + L
and AC + H groups at 2, 4, and 6 wk and the AC + M group at 2 wk were attenuated compared with that in the AC + V group, but
attenuation in the AC + M group was no longer evident after 4 wk.
LV/BW in the AC + L and AC + H groups over 6 wk was higher
than that in sham (n = 6-7 rats/group). Values are
means ± SE. *P < 0.01 vs. sham;
#P < 0.01 vs. the AC + V group;
##P < 0.05 vs. the AC + V group;
P < 0.01 vs. the AC + M group;
 P < 0.05 vs. the AC + M group.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
LV
end-diastolic dimension (LVEDD) in sham, AC + V, AC + L,
AC + H, and AC + M groups 2, 4, and 6 wk after operation.
LVEDD significantly increased in rats in the AC + V group at 2 wk
with further increases over 6 wk. Increases in LVEDD in the AC + L
and AC + H groups at 2, 4, and 6 wk and the AC + M group at 2 wk were attenuated compared with that in the AC + V group, but the
attenuation in the AC + M group was no longer evident after 4 wk.
LVEDD in the AC + L and AC + H groups over 6 wk was higher
than that in sham (n = 6-7 rats/group). Values are
means ± SE. *P < 0.01 vs. sham;
#P < 0.01 vs. the AC + V group;
##P < 0.05 vs. the AC + V group;
P < 0.01 vs. the AC + M group.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Relationship between LV/BW and diastolic WS. Correlation
between LV/BW and diastolic WS is significantly positive.
|
|
The expression levels of LV AM and ANP mRNA increased as LVH advanced
(Figs. 6 and
7, respectively). The
expression levels of AM and ANP mRNA in volume-overloaded rats were
increased 1.9- and 8.4-fold, respectively, at 6 wk compared with those
in sham-operated rats. More ANP mRNA (2.3- to 4.5-fold) than AM mRNA
was expressed at all times over 6 wk. The expression levels of AM mRNA
(Fig. 6) and ANP mRNA (Fig. 7) in the AC + H group over 6 wk were
suppressed to near-basal levels in sham-operated rats regardless of
incomplete suppression of LVH (Fig. 3). In contrast, the ANP mRNA
expression level in the AC + M group was also attenuated to some
extent over 6 wk (Fig. 7), whereas AM mRNA expression level in the
AC + M group was suppressed at 2 wk but not after 4 wk (Fig. 6).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 6.
Relative levels of mRNA for LV adrenomedullin (AM) in sham, AC + V, AC + L, AC + H, and AC + M groups 2, 4, and 6 wk
after operation. All mRNA levels are normalized for GAPDH mRNA. The
expression level of AM mRNA in the AC + V group at 2 wk was
significantly augmented with a gradual increase over 6 wk. Augmentation
of AM mRNA expression level was suppressed in the AC + L and
AC + H groups to near-basal levels in sham-operated rats. AM mRNA
expression level in the AC + M group decreased at 2 wk but was not
changed after 4 wk compared with that in the AC + V group
(n = 6-7 rats/group). Values are means ± SE.
*P < 0.01 vs. sham; **P < 0.05 vs.
sham; #P < 0.01 vs. the AC + V group;
##P < 0.05 vs. the AC + V group;
P < 0.01 vs. the AC + M group;
 P < 0.05 vs. the AC + M group.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Relative levels of mRNA for LV atrial natriuretic peptide (ANP) in
sham, AC + V, AC + L, AC + H, and AC + M groups 2, 4, and 6 wk after operation. All mRNA levels are normalized for GAPDH
mRNA. ANP mRNA expression level in the AC + V group at 2 wk was
significantly augmented with further increases over 6 wk. Augmentation
of ANP mRNA expression level was suppressed in the AC + L and
AC + H groups to near-basal levels in sham-operated rats. ANP mRNA
expression level in the AC + M group significantly decreased at 2 and 4 wk. Although not significant, ANP gene expression level at 6 wk
tended to decrease (n = 6-7 rats/group) compared
with that in the AC + V group. Values are means ± SE.
*P < 0.01 vs. sham; **P < 0.05 vs.
sham; #P < 0.01 vs. the AC + V group; ##P
< 0.05 vs. the AC + V group;  P < 0.05 vs.
the AC + M group.
|
|
 |
DISCUSSION |
Role of diastolic WS and ANG II in volume overload-induced LVH.
The present study demonstrated a positive correlation between diastolic
WS and LVH, indicating that diastolic WS is an important factor in
volume overload-induced LVH. Diastolic WS and LVEDP reached a plateau
at 2 wk and subsequently declined, whereas LV remodeling progressed and
diastolic WS was not normalized over 6 wk. Similar results have been
published by Brower et al. (2), who demonstrated that a
sustained increase in LVEDP, which peaked at 3 wk post-AC shunt, was
followed by a decrease in LVEDP regardless of further LV dilatation.
SBP decreased in the AC + H and AC + M groups but not in the
AC+L group, whereas LVEDP and diastolic WS were similarly reduced in
the AC + L, AC + H, and AC + M groups compared with the
AC + V group. The LVH at 2 wk was similarly attenuated among the
three groups compared with the AC + V group. However, LVH after 4 wk was blunted in the AC + H and AC + L groups but not in the
AC + M group. These findings indicate that the reduction in SBP
does not affect the attenuation of LVH, that the initial phase of LVH
was regressed by the reduction in LVEDP, and that the late phase of LVH
was attenuated by the reduction in LVEDP associated with
AT1 receptor inhibition. Furthermore, LV ANG II
concentrations in volume-overloaded rats were higher than those in sham
rats at 2 and 6 wk. Our results also support those of Iwai and
co-workers (16), who demonstrated that ANG-converting enzyme mRNA expression in the AC-shunted rat is significantly increased
compared with that in the sham-operated rat at 7 days and that the
significance is also revealed at 40 days. Taken together, these results
suggest that AC shunt-induced eccentric hypertrophy is partly regulated
by the RAS in addition to the mechanical stress of LVEDP and that a
load-dependent factor is involved during the early, rather than the
late, phase of LVH. We speculate that the specific contribution of RAS
to developing LVH in volume overload can relatively increase as an
alternative factor to mechanical stress after LVEDP decreases.
Liu et al. (21) found, in a rat model of myocardial
infarction, that AT2 antagonist alone did not affect LV
remodeling, whereas AT1 antagonist attenuated it, and that
this effect was blocked by concomitant use of the AT2
antagonist. These results suggest that the effect of candesartan might
be due to not only a blockade of the AT1 receptor but also
activation of the AT2 receptor in our model. However,
because we did not use an AT2 receptor antagonist in this
study, we could not determine whether or not blocking the
AT1 receptor or allowing unopposed AT2-mediated action is responsible for the reduced LVH. Other load-independent factors, such as endothelin, cytokines, and growth factors, might also
be involved in modulating volume overload-induced LVH in this model.
The expression levels of LV AM and ANP mRNA in volume overload.
Activation of the sympathetic nervous system and RAS maintains the
blood supply to vital organs in the acute AC shunt model (33). In contrast, ANP and AM are thought to act as
counterregulators, opposing these effects by vasodilatation and by
increasing salt and water excretion (1, 4). We confirmed
that LV AM mRNA as well as ANP mRNA is upregulated in this AC shunt
model, but the magnitude of the ANP expression level was 4.4-fold
higher than that of AM. These results are similar to those of Kaiser et
al. (17), who studied rats with myocardial infarction. In addition, we demonstrated that candesartan suppressed AM and ANP mRNA
expression to near-basal levels in the sham group over 6 wk and that
manidipine also suppressed ANP mRNA expression level to some extent
over 6 wk, whereas it suppressed the AM mRNA expression level at 2 wk
but not after 4 wk. This suggests that LVEDP and ANG II can modulate
both the AM and ANP mRNA expression level. However, the influence of
mechanical stress is more critical on the expression of ANP than of AM
mRNA. ANG II is a potent stimulator of ANP and AM synthesis (7,
19, 20). We (29) and Sadoshima et al.
(26) showed that the stretch-induced increase in the mRNA
expression of AM and ANP in cultured myocytes is significantly inhibited by AT1 receptor antagonist. Furthermore, we
observed that the AM mRNA level increased by ANG II stimulation in
myocytes is completely abolished by AT1 receptor antagonist
but not by AT2 receptor antagonist (29).
However, the role of AT2 signaling in AM gene expression
has not yet been completely elucidated. Taken together, we speculate
that LV AM and ANP transcription are regulated by both volume per se
and as an autocrine and/or paracrine response to the locally activated
RAS in the AC shunt-induced volume-overloaded model, whereas the
influence of volume overload per se seems to be more critical on the LV
ANP transcription. Our results agree with those reported by Ogawa et
al. (23), who stated that ANP expression is related to
both load-dependent and -independent components in the aortic banding
rat model and that the former is more important than the latter in
regulating ventricular ANP mRNA expression.
The possibility of direct or indirect effects of the calcium channel
blocker cannot be excluded. Blocking the Ca2+ influx could
influence the expression of AM mRNA, and the concomitant activation of
the cardiac RAS by manidipine may also have effects. Nevertheless, the
discrepancy between the suppression of ventricular AM and ANP gene
expression induced by manidipine indicates that the influence of the
RAS and mechanical stress on AM and ANP gene expression differs in the
cardiac hypertrophy induced by volume overload.
We also demonstrated that the levels of AM and ANP gene expression are
increased as LVH increases. The gene expression levels of AM and ANP
were completely suppressed, whereas LVH was partly attenuated by
candesartan in this study. We showed that ANG II stimulates AM
expression in cultured cardiac myocytes and cardiac fibroblasts and
that the secreted AM inhibits the hypertrophy of these cells in an
autocrine or paracrine manner (30, 31). The present
findings suggest that both AM and ANP are partly involved in the
development of volume overload-induced LVH in vivo. However, we could
not confirm a direct relationship between the expression of these genes
and LVH in this study. Further investigations are required to elicit
the pathophysiological contribution of AM and ANP to LVH or cardiac
function in volume overload.
In conclusion, the AT1 receptor antagonist candesartan
effectively suppressed volume overload-induced LVH, whereas the calcium channel blocker manidipine decreased diastolic WS and reduced the early
phase of LVH but could not suppress progressive LVH in volume overload.
Both diastolic WS and ANG II might be potent stimuli for the LVH in
this model. Diastolic WS might be relatively involved in the early
phase of LVH, whereas the RAS could be involved in the late, as well as
the early, phase of LVH. An increase in AM and ANP gene expression is
associated with the development of AC shunt-induced LVH. The augmented
levels of LV AM and ANP gene expression were completely suppressed by
candesartan. LV ANP expression level was also attenuated by manidipine,
whereas the LV AM expression level was suppressed by manidipine in the early, but not in the late, phase of volume overload. The expression levels of LV AM and ANP mRNA during volume overload are modulated by
both diastolic WS and ANG II, but the influence of diastolic WS seems
to be more critical on the gene expression of ANP than of AM.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Tsuneo Ogawa for helpful discussion, Mari Yanagita for
excellent technical assistance, and Norma Foster for critical reading
of the manuscript.
 |
FOOTNOTES |
This study was supported in by grants-in-aid for Scientific Research
from the Ministry of Education in Japan.
Address for reprint requests and other correspondence: T. Eto,
First Dept. of Internal Medicine, Miyazaki Medical College, Kihara
5200, Kiyotake, Miyazaki 889-1692, Japan (E-mail:
keto{at}post.miyazaki-med.ac.jp).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10 January 2000; accepted in final form 10 July 2000.
 |
REFERENCES |
1.
Braunwald, E.
Pathophysiology of heart failure.
In: Heart Disease (4th ed.). Philadelphia, PA: Saunders, 1992, p. 393-418.
2.
Brower, GL,
Henegar JR,
and
Janicki JS.
Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload.
Am J Physiol Heart Circ Physiol
271:
H2071-H2078,
1996[Abstract/Free Full Text].
3.
Bruckschlegel, G,
Holmer SR,
Jandeleit K,
Grimm D,
Muders F,
Kormer EP,
Reigger GA,
and
Schunkert H.
Blockade of renin-angiotensin system in cardiac pressure-overload hypertrophy in rats.
Hypertension
25:
250-259,
1995[Abstract/Free Full Text].
4.
Eto, T,
Kitamura K,
and
Kato J.
Biological and clinical roles of adrenomedullin in circulation control and cardiovascular disease.
Clin Exp Pharmacol Physiol
26:
371-380,
1999[ISI][Medline].
5.
Emery, JL,
and
Omens JH.
Mechanical regulation of myocardial growth during volume-overload hypertrophy in the rat.
Am J Physiol Heart Circ Physiol
273:
H1198-H1204,
1997[Abstract/Free Full Text].
6.
Florenzano, F,
and
Glantz SA.
Left ventricular mechanical adaptation to chronic aortic regurgitation in intact dogs.
Am J Physiol Heart Circ Physiol
252:
H969-H984,
1987[Abstract/Free Full Text].
7.
Focaccio, A,
Volpe M,
Ambrosio G,
Lembo G,
Pannain S,
Rubattu S,
Enea I,
Pignalosa S,
and
Chiariello M.
Angiotensin directly stimulates release of atrial natriuretic factor in isolated rabbit hearts.
Circulation
87:
192-198,
1993[Abstract/Free Full Text].
8.
Garcia, R,
and
Diebold S.
Simple, rapid, and effective method of producing aortocaval shunts in the rat.
Cardiovasc Res
24:
430-432,
1990[Abstract/Free Full Text].
9.
Grossmann, W.
Cardiac hypertrophy: useful adaptation or pathologic process?
Am J Med
69:
576-584,
1980[ISI][Medline].
10.
Grossman, W,
Jones D,
and
McLaurin LP.
Wall stress and patterns of hypertrophy in the human left ventricle.
J Clin Invest
56:
56-64,
1975.
11.
Harada, K,
Komuro I,
Shiojima I,
Hayashi D,
Kudoh S,
Mizuno T,
Kijima K,
Matsubara H,
Sugaya T,
Murakami K,
and
Yazaki Y.
Pressure overload induces cardiac hypertrophy in angiotensin type1a receptor knockout mice.
Circulation
97:
1952-1959,
1998[Abstract/Free Full Text].
12.
Harada, K,
Sugaya T,
Murakami K,
Yazaki Y,
and
Komuro I.
Angiotensin II type 1a receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction.
Circulation
100:
2093-2099,
1999[Abstract/Free Full Text].
13.
Hirano, S,
Imamura T,
Matsuo T,
Ishiyama Y,
Kato J,
Kitamura K,
Koiwaya Y,
and
Eto T.
Differential responses of circulating and tissue adrenomedullin and gene expression to volume overload.
J Cardiac Failure
6:
120-129,
2000[ISI][Medline].
14.
Isoyama, S,
Grossman W,
and
Wei JK.
Effect of age on myocardial adaptation to volume overload in the rat.
J Clin Invest
81:
1850-1857,
1989.
15.
Ito, H,
Hirata Y,
Adachi S,
Tanaka M,
Tsujino M,
Koike A,
Nagami A,
Marumo F,
and
Hiroe M.
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin-induced hypertrophy in cultured rat cardiomyocytes.
J Clin Invest
92:
398-403,
1993.
16.
Iwai, N,
Shimoike H,
and
Kinishita M.
Cardiac renin-angiotensin system in the hypertrophied heart.
Circulation
92:
2690-2696,
1995[Abstract/Free Full Text].
17.
Kaiser, M,
Kahr O,
Himada Y,
Smith P,
Kelly M,
Mahadeva H,
Adams M,
Lodwick D,
Aalkjaer C,
Avkiran M,
and
Samani NJ.
Differential regulation of ventricular adrenomedullin and atrial natriuretic peptide gene expression in pressure and volume overload in the rat.
Clin Sci (Colch)
94:
359-365,
1998[Medline].
18.
Komuro, I,
Katoh Y,
Kaida T,
Shibazaki Y,
Kurabayashi M,
Hoh E,
Takafu F,
and
Yazaki Y.
Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation.
J Biol Chem
266:
1265-1268,
1991[Abstract/Free Full Text].
19.
Latton, AL,
Michel JP,
Arnauld E,
Corvol P,
and
Soubrier F.
Myocardial recruitment during ANF mRNA increase with volume overload in the rat.
Am J Physiol Heart Circ Physiol
251:
H890-H896,
1986[Abstract/Free Full Text].
20.
Lear, W,
and
Boer PH.
Rapid activation of the type B versus type A natriuretic factor gene by aortocaval shunt induced cardiac volume overload.
Cardiovasc Res
29:
676-681,
1995[ISI][Medline].
21.
Liu, YH,
Yang XP,
Sharov VG,
Nass O,
Sabbah HN,
Peterson E,
and
Carretero OA.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure.
J Clin Invest
99:
1926-1935,
1997[ISI][Medline].
22.
Nishikimi, T,
Horio T,
Sasaki T,
Yoshihara F,
Takishita S,
Miyata A,
Matsuo H,
and
Kangawa K.
Cardiac production and secretion of adrenomedullin increased in heart failure.
Hypertension
30:
1367-1375,
1997.
23.
Ogawa, T,
Linz W,
Stevenson M,
Bruneau BG,
de Boid MLK,
Chen JH,
Edi H,
Scholkens BA,
and
de Boid AJ.
Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
Circulation
93:
2059-2067,
1996[Abstract/Free Full Text].
24.
Sadoshima, J,
and
Izumo S.
Molecular characterization of angiotensin-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
Circ Res
73:
413-423,
1993[Abstract/Free Full Text].
25.
Sadoshima, J,
Jahn L,
Takahashi T,
Kulik TJ,
and
Izumo S.
Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy.
J Biol Chem
267:
10551-10560,
1992[Abstract/Free Full Text].
26.
Sadoshima, J,
Xu Y,
Slayter HS,
and
Izumo S.
Autocrine release of angiotensin mediates stretch-induced hypertrophy of cardiac myocytes in vitro.
Cell
75:
977-984,
1993[ISI][Medline].
27.
Schrier, EW,
and
Abraham WT.
Hormones and hemodynamics in heart failure.
N Engl J Med
341:
577-585,
1999[Free Full Text].
28.
Schunket, H,
Dzau VJ,
Tang SS,
Hirsch AT,
Apstein CS,
and
Lorell BH.
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy.
J Clin Invest
86:
1913-1920,
1990.
29.
Tsuruda, T,
Kato J,
Kitamura K,
Imamura T,
Koiwaya Y,
Kangawa K,
Komuro I,
Yazaki Y,
and
Eto T.
Enhanced adrenomedullin production by mechanical stretch in cultured rat cardiomyocytes.
Hypertension
35:
1210-1214,
2000[Abstract/Free Full Text].
30.
Tsuruda, T,
Kato J,
Kitamura K,
Kawamoto M,
Kuwasako K,
Imamura T,
Koiwaya Y,
Tuji T,
Kangawa K,
and
Eto T.
An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth.
Cardiovasc Res
43:
958-967,
1999[Abstract/Free Full Text].
31.
Tsuruda, T,
Kato J,
Kitamura K,
Kuwasako K,
Imamura T,
Koiwaya Y,
Tuji T,
Kangawa K,
and
Eto T.
Adrenomedullin: a possible autocrine or paracrine inhibition of hypertrophic cardiomyocytes.
Hypertension
31:
505-510,
1998[Abstract/Free Full Text].
32.
Weinberg, EO,
Lee MA,
Weigner M,
Lindpaintner M,
Bishop SP,
Beniedict CR,
Ho KKL,
Douglas PS,
Chafizadeh E,
and
Lorell BH.
Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Circulation
95:
1592-1600,
1997[Abstract/Free Full Text].
33.
Willenbrock, R,
Stauss H,
Scheuermann M,
Osterziel KJ,
Unger T,
and
Dietz R.
Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity.
Am J Physiol Heart Circ Physiol
273:
H2580-H2585,
1997[Abstract/Free Full Text].
Am J Physiol Heart Circ Physiol 279(6):H2939-H2946
0363-6135/00 $5.00
Copyright © 2000 the American Physiological Society